HOUSTON, March 21, 2016 /PRNewswire/ -- The results of a recently published clinical trial demonstrate that AcceleDent®, an FDA-cleared pulsating device that accelerates orthodontic tooth movement by as much as 50 percent, also significantly reduces the pain associated with orthodontic treatment.
The peer-reviewed article published in the respected industry journal Angle Orthodontist, "Pain Control in Orthodontics Using a Micropulse Vibration Device: A Randomized Clinical Trial," shares the compelling results of how micropulse vibration, as used in AcceleDent, significantly lowers pain scores for overall pain during orthodontic treatment and biting pain.
The prospective, randomized controlled trial involved 58 orthodontic patients divided into an AcceleDent Group and a Control Group. Patients in both groups were directed not to take any pain medication or use topical ointments. The AcceleDent Group patients used their lightweight, hands-free pulsating device for the recommended 20 minutes per day and reported that they were in less pain throughout treatment than the patients who were in the Control Group. At a .05 significance level, a clear difference in overall pain for the AcceleDent Group versus the Control Group was detected (P= 0.002) and the same is true for the difference in biting pain between the two groups (P=0.003).
"We now have clinical proof to substantiate what patients have been telling us all along--that AcceleDent is the only technology that gives patients faster orthodontic treatment with less pain," said Michael K. Lowe, president and CEO of OrthoAccel® Technologies, Inc., which manufactures AcceleDent. "This randomized controlled trial was well-designed and the results are conclusive in further supporting why AcceleDent is the accelerated treatment solution preferred by the world's most respected orthodontists."
During the four-month study period, patients went to the orthodontist at the beginning of each month for adjustments and wire changes. Patients recorded incidence and severity of pain daily for the first seven days following the adjustment appointment and then weekly for the remainder of each month. Patients in the AcceleDent Group recorded pain scores within one hour of using the device.
"This study clearly demonstrates that, in addition to faster tooth movement, AcceleDent provides 'pure' pain management for orthodontic patients who frequently report discomfort during treatment," said Dr. Katie Graber of Graber Orthodontics. "I've found that patients and parents appreciate AcceleDent's reduction in discomfort because it eliminates the need for over-the-counter or prescription pain medication."
To read the peer-reviewed article, visit Angle Orthodontist.
About OrthoAccel® Technologies, Inc.
Based in Houston, Texas, OrthoAccel® Technologies, Inc. is a privately owned medical device company engaged in the development, manufacturing and marketing of products to enhance dental care and orthodontic treatment. OrthoAccel developed and sells AcceleDent®, the first FDA-cleared clinical approach to safely accelerate orthodontic tooth movement by applying gentle micropulses via SoftPulse Technology® as a complement to existing orthodontic treatment. More information can be found at acceledent.com and acceledent.co.uk or requested via email@example.com. Visit the company's Facebook page at Facebook.com/AcceleDent.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/study-shows-acceledent-reduces-pain-and-discomfort-during-orthodontic-treatment-300238816.html
SOURCE OrthoAccel Technologies, Inc.